Ophthalmology · Los Gatos, CA
NPI
1093778326
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
431 Monterey Ave, Suite 3
Los Gatos, CA, 95030
Phone (408) 354-9510
Groups this clinician bills Medicare through
Medicare paid, 2024
$447K
4,595 services
Medicare patients, 2024
1,012
Average age 78
Drug cost, 2024
$652K
4,243 prescriptions
Company payments, 2025
$1,270
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher J Engelman was code 99213 (office e&m - established), 1,142 times for 649 patients. In total Christopher J Engelman billed 4,595 services in 48 codes, and Medicare paid $447K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,142 | 649 | $84.86 | $97K |
| 92133 Computerized Ophthalmic Imaging | Office | 652 | 591 | $35.94 | $23K |
| 92083 Vision, Hearing, and Speech Services | Office | 515 | 462 | $65.52 | $34K |
| 99214 Office E&M - Established | Office | 420 | 376 | $106.61 | $45K |
| 92250 Angiography | Office | 383 | 370 | $37.79 | $14K |
| 92014 Ophthalmological E&M | Office | 337 | 337 | $134.36 | $45K |
| 92020 Ophthalmological E&M | Office | 246 | 225 | $25.75 | $6,334 |
| 92134 Computerized Ophthalmic Imaging | Office | 153 | 131 | $41.09 | $6,287 |
| 66984 Cataract Surgery | Facility | 98 | 59 | $537.72 | $53K |
| 99204 Office E&M - New | Office | 74 | 74 | $130.63 | $9,667 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 70 | 47 | $240.38 | $17K |
| 92136 Ultrasound - Nonspecific | Office | 67 | 65 | $45.57 | $3,053 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 60 | 59 | $16.17 | $970 |
| 66821 Cataract Surgery | Office | 52 | 46 | $339.87 | $18K |
| 76514 Ultrasound - Nonspecific | Office | 49 | 48 | $9.49 | $465 |
By year: 2022 $530K for 5,126 services; 2023 $455K for 4,678 services; 2024 $447K for 4,595 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher J Engelman prescribed most often to Medicare patients was Latanoprost, with 1,258 prescriptions and refills. In total Christopher J Engelman wrote 4,243 Medicare prescriptions that cost $652K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,258 | 2,747 | 342 | $15K |
| Timolol Maleate Generic | 525 | 1,146 | 157 | $5,588 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 381 | 738 | 107 | $5,759 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 226 | 389 | 61 | $131K |
| Dorzolamide Hcl Generic | 197 | 408 | 65 | $3,425 |
| Brimonidine Tartrate Generic | 175 | 360 | 57 | $4,441 |
| Prednisolone Acetate Generic | 169 | 278 | 110 | $8,399 |
| Moxifloxacin Moxifloxacin Hcl | 149 | 149 | 98 | $2,657 |
| Diclofenac Sodium Generic | 128 | 178 | 92 | $1,314 |
| Restasis Cyclosporine | 105 | 187 | 27 | $116K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 99 | 183 | 24 | $14K |
| Vyzulta Latanoprostene Bunod | 96 | 153 | 21 | $42K |
| Lumigan Bimatoprost | 73 | 155 | 19 | $41K |
| Cyclosporine Generic | 67 | 129 | 25 | $33K |
| Brinzolamide Generic | 66 | 124 | 20 | $9,489 |
Brand drugs: 1,976 claims; generic drugs: 2,267 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher J Engelman $1,270 ($1,270 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $415.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.